Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Conference Coverage
Warfarin use linked to knee and hip replacement in osteoarthritis patients
Publish date:
November 7, 2020
FROM ACR 2020
SOURCE:
Ballal P et al. Arthritis Rheumatol. 2020;72(suppl 10):
Abstract 0934
.
Pages
« first
1
2
Recommended Reading
FDA: Continue Study of Antinerve Growth Factors for Pain
MDedge Hematology and Oncology
FDA Approves REMS for Long-Acting Opioids
MDedge Hematology and Oncology
VIDEO: Use fiduciary duty to set pain medication boundaries
MDedge Hematology and Oncology
VIDEO: Consistency is key to monitoring patients on opioids
MDedge Hematology and Oncology
Glucocorticoids increase risk of S. aureus bacteremia
MDedge Hematology and Oncology
FDA: New labeling warns against combining opioids, benzodiazepines
MDedge Hematology and Oncology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Hematology and Oncology
Hemophilia carriers face elevated risk of joint comorbidities
MDedge Hematology and Oncology
Advice on treating rheumatic diseases from a COVID-19 epicenter
MDedge Hematology and Oncology
New ‘atlas’ maps links between mental disorders, physical illnesses
MDedge Hematology and Oncology
Thrombosis
All Specialties
